Zhicong Yang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 08, 2025
Bisulfite-free PCDHGB7 methylation in urine enables early noninvasive detection of urothelial carcinoma.
Journal: Bioengineering & translational medicine
Published: October 05, 2024
Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma.
Journal: Journal of translational medicine
Published: April 03, 2024
Highly homologous miR-135a and miR-135b converting non-small cell lung cancer from suppression to progression via enhancer switching.
Journal: Human molecular genetics
Published: December 11, 2023
PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study.
Journal: BMC medicine
Published: October 25, 2023
Mutually exclusive epigenetic modification on SIX6 with hypermethylation for precancerous stage and metastasis emergence tracing.
Journal: Signal transduction and targeted therapy
Published: January 04, 2022
Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression.
Journal: Signal transduction and targeted therapy
Published: November 05, 2021
UHRF1 regulates alternative splicing by interacting with splicing factors and U snRNAs in a H3R2me involved manner.
Journal: Human molecular genetics
Published: February 26, 2021
COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020.
Journal: Emerging infectious diseases
Published: September 12, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026